Clearance Summary
HemosIL Chromogenic Factor IX received FDA 510(k) clearance under submission number K230852, sponsored by Instrumentation Laboratory Company. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 2023-12-13.
- Submission: K230852
- Applicant / Sponsor: Instrumentation Laboratory Company
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.7290
- Decision date: 2023-12-13
Classification & Regulation
This clearance is catalogued under FDA product code GGP and 21 CFR 864.7290, within the Hematology review panel as a Class II device.